Navigation Links
Iomai Announces Year-End 2007 Financial Results and Business Progress
Date:3/6/2008

836 621

Net loss before cumulative effect of a

change in accounting principle (28,274) (31,802)

Cumulative effect of change in accounting

principle - 17

Net loss (28,274) (31,785)

Dividends on and accretion of convertible

preferred stock - (471)

Net loss available to common stockholders $(28,274) $(32,256)

Net loss available to common stockholders

per share of common stock - basic and diluted $(1.16) $(2.03)

Weighted-average number of shares of

common stock - basic and diluted 24,412,688 15,915,797

SELECTED BALANCE SHEET DATA (Unaudited)

(In thousands)

December 31,

2007 2006

`

Cash and cash equivalents and unrestricted

marketable securities $15,500 $15,336

Accounts receivable 4,011 62

Total assets 27,355 23,085

Total debt and capital lease obligations 3,655 4,759

Total liabilities 9,402 9,050

Accumulated deficit (129,062) (100,788)

Total stockholders' equity 17,953 14,035


'/>"/>
SOURCE Iomai Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Iomai to Announce Fourth Quarter and Year-End 2007 Financial Results and Host Webcast on Thursday, March 6
2. Iomai CEO to Speak at BIO CEO & Investor Forum on Feb. 12
3. Iomai to Announce Third Quarter 2007 Financial Results and Host Webcast on Tuesday, November 13
4. Iomai Chief Scientific Officer Dr. Gregory Glenn Details Development of Travelers Diarrhea Patch at Keystone Conference
5. Iomai CEO to Speak at Natixis Bleichroeder Hidden Gems Conference on Monday
6. Dragon announces new product launch; increase in annual production output capacity
7. Edwards Lifesciences Announces First Human Implants of Next-Generation Transcatheter Heart Valve
8. China Yingxia International Announces Q4 and FY 2007 Estimates
9. Bristol-Myers Squibb Announces Dividend
10. deCODE genetics Announces Webcast of Conference Call to Discuss Full-year 2007 Financial Results
11. Maxygen Announces Management Changes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... PALO ALTO, Calif. (PRWEB) , ... July 02, 2015 , ... ... designed to improve an individual’s quality of sleep, launched its Indiegogo campaign on June ... and functionality: Luzi's voice command technology makes it effortless to use, while the integration ...
(Date:7/1/2015)... , ... July 01, 2015 , ... It is now ... (TBI) using single photon emission computed tomography (SPECT) according to researchers from ... which examined over 20,000 brain scans and is believed to be the largest brain ...
(Date:7/1/2015)...   Decision Resources Group finds that ... are its oral administration, alternative mechanism of action, ... rheumatologists. Otezla was the first oral therapy specifically ... psoriatic arthritis in the United States ... conventional oral treatments including disease-modifying antirheumatic drugs (DMARDs), ...
(Date:7/1/2015)... and BANGALORE, India , July 1, ... company that uses next generation sequencing technology to empower ... A. Storrer as chief executive officer. In his ... be responsible for all strategy, business expansion and worldwide ... has served as Strand,s chairman and CEO since its ...
Breaking Biology Technology:Luzi Smart Lamp Recently Launched Indiegogo Campaign 2Luzi Smart Lamp Recently Launched Indiegogo Campaign 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 2Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 3Brain Scans Can Tell Post-Traumatic Stress Disorder and Traumatic Brain Injury Apart According to New Research by Amen Clinics 4Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 2Surveyed Rheumatologists Report That Otezla's Oral Administration is its Single Greatest Advantage Over Currently Available Treatment Options 3Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 2Strand Life Sciences Names Scott A. Storrer CEO as Company Continues Global Expansion with Focus on Precision Medicine Product 3
... June 19 Canopus,BioPharma, Inc. (OTC: CBIA), has ... a tumor reducing agent and has also demonstrated ... both cisplatin and,cetuximab (Erbitux) in two mice lung ... Patrick Prendergast, stated, "We at,Canopus are encouraged with ...
... Neuftec,Limited, the proprietor of the original nano-particulate cerium ... against Oxonica Energy,Limited, a wholly owned subsidiary of ... the High Court of Justice, has commented on ... Dr Matthews,(CEO) on 19 June 2008., Dr ...
... features Asian biopharmaceutical industry information on ... ... 19 BioSpace, the world,s,leading online community for the bioscience ... pharmaceutical and,medical devices industries in Asia. AsiaBio(TM) features dynamic,informational Hotbed ...
Cached Biology Technology:CB1400, Patented by Canopus BioPharma, Prevents Tumor Growth and Enhances the Anti-Tumor Effects of Cisplatin and Cetuximab (Erbitux). 2Neuftec Responds to a Fundamental Inaccuracy in Oxonica PLC's Regulatory Announcement 2BioSpace Announces New Online Community for Asia 2
(Date:6/24/2015)... Biometry authentication provider KeyLemon today announced ... one face in. Logo - ... in, entering the expanding biometric authentication market in ... answer to the password problem. With advanced face ... KeyLemon, one face in allows users to securely ...
(Date:6/23/2015)... N.C. , June 23, 2015   ... today announced the results of a recent study ... accuracy on the wrist during activity. In a ... technology was compared along with the Apple Watch ... accurately measuring heart rate during activity. The study ...
(Date:6/18/2015)... , June 18, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market announces that ... featured segment on "Money on the Mark", scheduled to air ... June 20 th . The ... be from 7:00 to 8:00pm EST. NXT-ID, Inc.,s CEO ...
Breaking Biology News(10 mins):KeyLemon Announces Partnership With Biometric Password Solution onefacein 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 2Valencell Delivers Breakthrough Heart Rate Accuracy on the Wrist 3NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3
... identified a key gene mutation responsible for type 2 diabetes ... The study, which originated in Italy and was validated ... to a major drop in the body,s ability to make ... the cell to absorb sugar. This drop in insulin receptors ...
... The American Heart Association estimates 35 percent of adults in ... factors characterized by obesity and the simultaneous presence of heart ... lipids. In patients with metabolic syndrome, high blood pressure ... affects the organ,s ability to filter waste from the body. ...
... able to navigate to specific locations up to 50km away, ... Journal of Animal Ecology has found. Re-analysing tracking data ... as blacktip reef sharks swim in a pattern known as ... times hunt for prey or mates by using "directed walks", ...
Cached Biology News:Type 2 diabetes linked to single gene mutation in 1 in 10 patients 2Study shows pine bark naturally improves kidney function in patients with metabolic syndrome 2Study shows pine bark naturally improves kidney function in patients with metabolic syndrome 3Shark tracking reveals impressive feats of navigation 2
Taq DNA Polymerase (cloned), 250 units. Category: Nucleotides & Enzymes & Biochemicals, Modifying Enzymes, Polymerases....
Ps-Aeruginosa (IgA) -Ab EIA Sample Size: 100 l...
...
...
Biology Products: